What is US Biosecure Act and Its Implications
Washington, 24th August 2024: The United States is poised to enact the US Biosecure Act, a groundbreaking legislation that will significantly influence the global biotechnology and pharmaceutical sectors. This Act aims to bolster national security by restricting US federal agencies from engaging with “biotechnology companies of concern,” particularly those associated with China. Key players on this list include companies like BGI, MGI, Complete Genomics, WuXi AppTec, and WuXi Biologics, which are perceived as threats to US interests. The implementation of this Act could unlock considerable opportunities for India's pharmaceutical sector, provided that India enhances its regulatory frameworks to guarantee the safety and effectiveness of its offerings.
National Security Considerations
...